Join us as Morris Miller, CEO of Xenex, shares how the LightStrike+ Microbial Reduction Robot is transforming patient safety through innovative technology and evidence-based research. Learn about the challenges Xenex overcame to achieve FDA approval and how they’re making a significant impact in healthcare facilities worldwide.